Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: Pan-cancer analysis identifies CLEC12A as a potential biomarker and therapeutic target for lung adenocarcinoma

Fig. 5

Immune landscape of CLEC12A in pan-cancer. (A) The links between the ESTIMATE scores (ESTIMATE score, Immune score, and Stromal score) and CLEC12A expression in pan-cancer. (B) Seven software were employed to analyze the links between CLEC12A expression and immune cell infiltration in pan-cancer. (C-E) The relationships between CLEC12A expression and TMB(C), MSI(D), and NEO(E) were displayed by the radar chart. (F, G) The expression of CLEC12A in valid cohort(R) and invalid cohort(N) and proportion of immunotherapy response between high- and low-CLEC12A cohorts in two Melanoma cohorts receiving ICB therapy

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us